Why pharmacists should manage pre-operative opioid use
Patients are “crying out” for help with opioid dose reduction according to evidence gathered during the OpioidHALT study and the impressive results have led to funding of $1.5 […]
Patients are “crying out” for help with opioid dose reduction according to evidence gathered during the OpioidHALT study and the impressive results have led to funding of $1.5 […]
Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D). Researchers reported this […]
The results of the OpioidHALT pilot study show that 90% of patients reduced their opioid doses by at least 50% compared with 17% in the control group and […]
A new study reveals that young patients treated with psychiatric medications receive potentially dangerous combinations with concerning frequency. Researchers from Rutgers Health and other institutions analyzed New York […]
The OpioidHALT intervention is tailored to the needs of individual patients and evaluated for safety by a pain specialist. Shared decision-making, with the patient, is an important feature […]
FIP’s Early Career in Pharmaceutical Practice Recognition Award recognises an outstanding early career pharmacist who has made significant contributions to the field at a national level and is […]
Opioid doses can be successfully reduced by a pharmacy-led intervention, according to a randomised study led by Dr Shania Liu and Dr Jonathan Penm at the University of […]
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the […]
French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once […]
Nearly half of counties in the United States have at least one ‘pharmacy desert’ where there is no retail pharmacy within 10 miles, according to a new study […]
Up to 74% of adults with treatment-resistant high blood pressure were able to get their blood pressure below 140/90 mm HG within one year through a program combining […]
The EU medicines regulator, the European Medicines Agency (EMA), has announced plans to support its counterparts in African countries – paving the way for the creation of a […]